N@N

Deepa Raghavan Maintained (TMHC) at Hold with Decreased Target to $25 on, Jun 17th, 2022

^{Published on 2024-10-27 21:33:35 - WOPRAI, Deepa Raghavan}
 

Deepa has made no other calls on TMHC in the last 4 months.

There are 4 other peers that have a rating on TMHC. Out of the 4 peers that are also analyzing TMHC, 3 agree with Deepa's Rating of Hold. Following are those relevant analyst calls for the last 4 months

• Alex Rygiel of "B. Riley Securities" Downgraded from Strong Buy to Hold and Decreased Target to $28 on, Thursday, June 16th, 2022
• Daniel Oppenheim of "Credit Suisse" Initiated at Hold and Held Target at $32 on, Tuesday, April 5th, 2022
• Matthew Bouley of "Barclays" Downgraded from Buy to Hold and Decreased Target to $33 on, Thursday, March 31st, 2022

This is the rating of the analyst that currently disagrees with Deepa

• Michael Rehaut of "JP Morgan" Maintained at Buy with Decreased Target to $30 on, Wednesday, April 13th, 2022